On October 6th I told readers to look into Johnson & Johnson (JNJ). Today JNJ hit another 52-week high. Readers could have made a quick 4.7%. For the risk averse, Nabi Biopharma (NABI) is up 14% since I mentioned it and NeoPharm (NEOL) is up a HEFTY 41%. Nice work Big Ben! I wish I had followed my own advice.